Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.450
0.00 (0.00%)
Sep 25, 2025, 8:00 PM EDT
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$234,216
Profits / Employee
-$682,121
Market Cap
261.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Jushi Holdings | 1,234 |
Silence Therapeutics News
- 12 days ago - Silence Therapeutics (SLN) Receives Reiterated Buy Rating from HC Wainwright | SLN Stock News - GuruFocus
- 19 days ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire
- 7 weeks ago - Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera - Business Wire
- 5 months ago - Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 5 months ago - Silence Therapeutics Welcomes Tim McInerney to Board of Directors - Business Wire
- 7 months ago - Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference - Business Wire